ClinicalTrials.Veeva

Menu

Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS (NIRS-RBD)

C

Clinique Beau Soleil

Status

Completed

Conditions

Parkinson Disease

Treatments

Other: Near Infrared Spectroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT03060239
2016-A01532-42

Details and patient eligibility

About

The purpose of this study is to confirm the improvement of movement during RBD in Parkinson's disease and to explore the neuronal network involved in this improvement using NIRS.

Full description

The aim of this study is to compare the quality of movement during REM sleep during RBD episodes and movement awake without and with dopaminergic treatment while measuring cortical activity using NIRS.

Enrollment

13 patients

Sex

All

Ages

40 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Idiopathic Parkinson's Disease (Hughes AJ et al., 2001)
  • Patients with REM sleep behaviour sleep disorder according to the ICSD2 (International Classification of Sleep Disorders 2) criteria and frequent reported several times per week by the spouse
  • Informed written consent signed
  • Patient aged 40 to 90 years
  • Affiliate or benefiting from a social security scheme.

Exclusion criteria

  • Atypical Parkinson's Syndromes

  • Patient not accepting polysomnography

    • Contraindications to cerebral Magnetic Resonnance Imaging (MRI): pacemaker, cochlear implants, certain heart valves, claustrophobia, pregnancy.
    • Limit of validity of the MRI: if the patient presents dyskinesias preventing immobile maintenance of a few minutes in the MRI for the acquisition of images

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

Experimental arm
Experimental group
Description:
Patients with Parkinson's disease with severe REM sleep behaviour disorder according to International Classification of Sleep Disorders (ICSD2) criteria.
Treatment:
Other: Near Infrared Spectroscopy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems